UBS Maintains Neutral on Accenture, Raises Price Target to $400
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Kevin Mcveigh has maintained a Neutral rating on Accenture (NYSE:ACN) and increased the price target from $365 to $400.
January 25, 2024 | 7:39 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UBS has maintained a Neutral rating on Accenture and raised the price target to $400, indicating a positive outlook on the company's stock value.
The increase in price target by UBS suggests an improved outlook on Accenture's future performance, which could lead to increased investor confidence and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100